pharmacophore-modeling

To build a 3D pharmacophore model for virtual screening, provide a protein structure and ligand data. The model extracts pharmacophore features to identify potential drug-like molecules and scaffold-hopping candidates.

Ligand-based pharmacophore modeling extracts features from a set of bioactive compounds, whereas receptor-based modeling derives pharmacophores directly from protein binding-pocket structures to map ligand-receptor interactions.

You can generate novel molecules for de novo design by applying a constructed 3D pharmacophore model as a structural constraint. This ensures newly generated candidate molecules match the required ligand-receptor interaction features.

Yes, you need RDKit and PLIP along with Pharmer, Pharmit, and PharmacoForge. These dependencies handle cheminformatics processing, binding pocket analysis, and 3D model construction for receptor-based studies.

Yes, pharmacophore-based virtual screening identifies scaffold-hopping candidates by matching the spatial arrangement of chemical features against large compound libraries, independent of the original chemical scaffold.

The 3D pharmacophore model requires accurate protein structure or bioactive ligand data for feature extraction. Modeling success depends on the quality of the binding-pocket structure and the definition of interaction constraints.